4-THIAZOLECARBOXYLIC ACID, 2-(5-(5-(3-FLUORO-4-((METHYLAMINO)CARBONYL)PHENYL)-8-OXO-6-THIOXO-5,7-DIAZASPIRO(3.4)OCT-7-YL)-3-(TRIFLUOROMETHYL)-2-PYRIDINYL)-4,5-DIHYDRO-
UNII WP3N26Z5H4
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-thiazolecarboxylic Acid, 2-(5-(5-(3-fluoro-4-((methylamino)carbonyl)phenyl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)oct-7-yl)-3-(trifluoromethyl)-2-pyridinyl)-4,5-dihydro-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WP3N26Z5H4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408596-35-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H19F4N5O4S2 JBORWYHHOOUNRM-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-thiazolecarboxylic Acid, 2-(5-(5-(3-fluoro-4-((methylamino)carbonyl)phenyl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)oct-7-yl)-3-(trifluoromethyl)-2-pyridinyl)-4,5-dihydro-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.